Starling Oncology TOI
TOI
$6.20 +0.01 (+0.16%)
At close: Aug 11, 2026 · 4:00 PM EDT

Oncology Institute, Inc. (TOI) Short term Debt (2020 - 2021)

Oncology Institute's (TOI) quarterly Short term Debt came in at $183000.0 in Q4 2021, down 96.59% YoY from $5.4 million in Q4 2020, and down 96.59% on a QoQ basis from $5.4 million in Q4 2020.

Oncology Institute, Inc. (TOI) Short term Debt (2020 - 2021) Analysis & Trends

Oncology Institute (TOI) has 2 years of Short term Debt data on file, last reported at $183000.0 in Q4 2021.

  • Quarterly Short term Debt fell 96.59% year-over-year to $183000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $183000.0 (down 96.59% YoY) and the FY2021 annual result came in at $183000.0, down 96.59% from the prior year.
  • Short term Debt fell to $183000.0 in Q4 2021, from $5.4 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $5.4 million in Q4 2020 to a low of $183000.0 in Q4 2021.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2021 183,000.00
Dec 31, 2020 5.37 Mn